Zdrowie i gospodarka · 14/12/2016

FDA Announces Guidance on Emerging Postmarket Medical Device Signals

The Food and Drug Administration (FDA) has released a guidance document outlining its policy for notifying the public about emerging signals in postmarket medical devices, aiming to provide healthcare providers, patients, and consumers with timely access to the most current information about device performance and potential risks and benefits.